2023-2024 COVID-19 Vaccine Efficacy Wanes Over Time
Drug Topics
JULY 21, 2025
A new study reveals the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.
2024 Related Topics 
5 Ways To Celebrate Antibiotic Awareness Week 2024
IDStewardship
NOVEMBER 18, 2024
This article discusses ways to celebrate the annual observance of antibiotic awareness week 2024. In 2024 USAAW and WAAW is November 18th through 25th. RECOMMENDED FOR YOU The post 5 Ways To Celebrate Antibiotic Awareness Week 2024 appeared first on IDStewardship. Written by: Timothy P. Gauthier, Pharm.D.,
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pneumococcal Vaccine Rates Low Despite Updated Recommendations
Drug Topics
JULY 11, 2025
Pneumococcal Hemolytic Uremic Syndrome Increased Among Children Over Last 15 Years Brian Nowosielski June 18th 2025 Article Researchers explored the incidence of pneumococcal hemolytic uremic syndrome in children living in Sweden from January 2009 to December 2024.
CPESN USA Honors 32 Community-Based Pharmacies; Awards Sponsored by Compliant Pharmacy Alliance (CPA)
Drug Topics
JULY 8, 2025
Recent Videos Related Content Flip The Pharmacy April Schedule & Sign-Up March 28th 2024 Article Check out these can't-miss Workflow Wednesdays sessions in April. Flip The Pharmacy March Schedule & Sign-Ups March 4th 2024 Article Check out these can't-miss Workflow Wednesdays sessions in March.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT
Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting
Drug Topics
JUNE 6, 2025
Updated October 11, 2024. Updated October 11, 2024. Updated July 15, 2024. May 15, 2024. The Immunization Action Coalition. Travel Vaccines. Accessed May 16, 2025. Travelers’ Health. Accessed May 16, 2025. Plan for Travel. Accessed May 16, 2025. Yellow Fever Vaccine. Accessed May 16, 2025.
Pharmacy Schools Should Prepare Students for Workforce Challenges
Drug Topics
JULY 9, 2025
But in 2024, that number fell to just 2.8%.” Specifically focused on coping mechanisms, work environment, pharmacist advice to students, and their influence on student career paths, researchers distributed a 22-question survey to pharmacy students in Pennsylvania during the spring 2024 semester. December 3, 2024. June 16, 2025.
Preparing Students for the Technology of Tomorrow
Drug Topics
AUGUST 8, 2025
12,13 The American Medical Association surveyed physicians on AI utilization and found that by 2024, nearly two-thirds of physicians had used at least 1 AI tool. March 21, 2024. The top 15 specialty pharmacies of 2024: how PBMs, health systems, and independents are shaping the market. December 16, 2024. News release.
FDA Approves Widaplik for Treatment of Hypertension
Drug Topics
JUNE 9, 2025
2024 Dec 10;84(24):2393-2403. Epub 2024 Aug 31. 2024 Oct 19;404(10462):1536-1546. Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension. J Am Coll Cardiol. doi: 10.1016/j.jacc.2024.08.025. 2024.08.025. PMID: 39217570. doi: 10.1016/S0140-6736(24)01744-6.
Independent Pharmacists’ Unique Role During Disaster Management Efforts
Drug Topics
JUNE 11, 2025
From 1980 to 2024, the National Centers for Environmental Information reported 403 confirmed natural disaster events impacting weather or climate, totaling economic losses over $1 billion. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.
Independent Pharmacies Opening, Closing More Than Chain Storefronts
Drug Topics
AUGUST 15, 2025
3 Even more recently, a total of 2275 pharmacies closed in the first 9 months of 2024 and an additional 300 closed by March of this year. December 3, 2024. 2275 pharmacies have closed so far in 2024. September 2024. August 16, 2024. US News & World Report. Accessed August 15, 2025. Health Affairs. Drug Topics.
Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End
Drug Topics
JULY 10, 2025
PwC’s 2024 Voice of the Customer report found that 80% of consumers are willing to pay more for sustainably produced or sourced goods, despite overall rising costs. sustainability premium, even as cost-of-living and inflationary concerns weigh: PwC 2024 Voice of the Consumer Survey. April 2025. Consumers willing to pay 9.7%
Q&A: Factors Influencing Perception of Pharmacy as a Career
Drug Topics
JULY 25, 2025
The 2024 National Pharmacist Workforce Study reveals a profession under pressure. Final Report of The 2024 National Pharmacist Workforce Survey. Pharmacy Workforce Center; Washington, DC, USA: 2024. 1 Pharmacists report increasing dissatisfaction tied to workplace stress, corporatization, and a lack of flexibility. References 1.
KPI Optimization In Independent Pharmacy: Top 5 Blogs From 2024
DiversifyRx
JANUARY 2, 2025
Below is DiversifyRx’s top blogs discussing KPI optimization in 2024. Top 5 Blogs for KPI Optimization in 2024: “ The KPIs Every Pharmacy Should Track Right Now “ Uncover the must-have metrics for monitoring your pharmacys success. Ignoring KPIs is like flying blind in turbulent skies.
Life sciences response to 2024 Autumn Budget
European Pharmaceutical Review
OCTOBER 31, 2024
Announcement of the UK Government’s 2024 Autumn Budget on 30 October marks the first Labour budget in 14 years. UK manufacturing and R&D to benefit from new £360m investment The post Life sciences response to 2024 Autumn Budget appeared first on European Pharmaceutical Review.
Five Key Skills for Pharmacy Residents
IDStewardship
JANUARY 8, 2025
Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D.,
Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable
Drug Topics
JUNE 18, 2025
March 21, 2024. KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs. May 10, 2024. As obesity rates rise in the U.S. and worldwide, new weight-loss drugs surge in popularity. Pew Research Center. June 18, 2025. Montero A, Sparks G, Persiado M, Hamel L. June 18, 2025.
FDA Approves Nitisinone for Treatment of Alkaptonuria
Drug Topics
JUNE 19, 2025
FDA Grants Interchangeability Designation to Adalimumab-Bwwd for Humira Ashley Gallagher May 28th 2025 Article This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.
Pharmacy Team Development: Top Blogs of 2024
DiversifyRx
FEBRUARY 4, 2025
Top 5 Pharmacy Team Development Blogs from DiversifyRx in 2024: “ Pharmacy Profit Through Soft Skills “ This blog emphasizes the importance of soft skillssuch as communication, empathy, and emotional intelligencein driving pharmacy profit. The post Pharmacy Team Development: Top Blogs of 2024 first appeared on DiversifyRx.
Newsletter – September 2024
Fuld
SEPTEMBER 23, 2024
Register Now The post Newsletter – September 2024 appeared first on Fuld & Co. Join our webinar where our expert panel will explore the opportunities and challenges AI brings to deal-making, offering insights into its growing role in deal-making and the future of investment banking.
Pharmacists Demonstrate Professional Identity Through Provider, Patient-Focused Roles
Drug Topics
JULY 21, 2025
In August 2024, the American Medical Association (AMA), the advocacy group for US physicians, wrote a letter to US Congress opposing legislation that would allow pharmacists to test and treat patients with specific illnesses. 2024 Sep 24;46:101088. August 9, 2024. Muscat NA, Sinclair P, Zapata T, et al. Lancet Reg Health Eur.
Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study
Drug Topics
JULY 16, 2025
FDA Grants Interchangeability Designation to Adalimumab-Bwwd for Humira Ashley Gallagher May 28th 2025 Article This designation follows Hadlima’s low-concentration prefilled syringes and single-dose vials, which were designated in June 2024.
Pharmacist, Provider Partnership Can Help Increase RSV Vaccine Uptake
Drug Topics
AUGUST 12, 2025
Data for the prospective multisite survey study was gathered from 2 chain grocery stores in Maryland between December 2023 and March 2024. For the study, a survey was given to eligible patients who came to the pharmacy.
STAT+: FDA’s new guidance on AI in drug development centers the risk introduced by the technology
STAT
JANUARY 6, 2025
The FDA’s new draft guidance comes on the heels of a reflection paper from the European Medicines Agency on the use of AI in the drug product lifecycle, finalized in September 2024.
ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust
Drug Topics
JUNE 20, 2025
Pneumococcal Burden Remains Despite Immunization Expansion Ashley Gallagher June 9th 2025 Article The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024. Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting Gretchen K.
Megablockbusters are the holy grail. Here’s how drugmakers are getting there.
PharmaVoice
JUNE 23, 2025
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.
How the Rise in US Pharmacy Deserts Impacts Patients’ Health
Drug Topics
AUGUST 4, 2025
October 25, 2024. More US pharmacies closed than opened in 2018–21; independent pharmacies, those in Black, Latinx communities most at risk. Health Affairs. 2024;43(12):1703-1711. Struggles at CVS, Rite Aid, and Walgreens call into question retail pharmacy’s future. Murphy M, Rodis J. The growing crisis of pharmacy deserts. April 28, 2025.
Gaps Remain in MOUD Access Across Opioid Treatment Programs
Drug Topics
JUNE 30, 2025
In the cross-sectional study, investigators used data from the 2018 to 2024 Mental Health and Addiction Treatment Tracking Repository. However, data on low-dose initiation compared with traditional initiation is still limited.
How cinnamon lowers blood sugar
The Checkup by Singlecare
NOVEMBER 4, 2024
In September 2024, Consumer Reports tested 36 popular brands of ground cinnamon. Less serious but still notable side effects of increasing your cinnamon intake include mouth sores, per Palinski-Wade, as well as gastrointestinal discomfort and headache, according to Dr. Sapola.
Q&A: How IQVIA Keeps Pharmacists Engaged with US Prescription Drug Use
Drug Topics
JULY 14, 2025
Dynamics that have become apparent during 2024 have driven significant revisions to the outlook, and in this report, the drivers of change in medicine spending over the next 5 years are deconstructed to enable better understanding,” wrote IQVIA. There [were] up to 48 novel drugs launched in the US in 2024; 31 of them were orphan drugs.
FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog
Drug Topics
JULY 21, 2025
May 15, 2024. Biocon Biologics expands diabetes portfolio with FDA approval of Kirsty, the first and only interchangeable rapid-acting insulin aspart in the United States. News release. Biocon Biologics. July 15, 2025. Accessed July 21, 2025. National Diabetes Statistics Report. Accessed July 21, 2025. Kirsty [package insert].
STAT+: Health AI investments are off to a roaring start in 2025
STAT
JANUARY 15, 2025
According to data published this week by advisory Rock Health, startups using AI made up 37% of 2024’s digital health funding. Since OpenAI’s ChatGPT launched a wave of enthusiasm about the potential of AI, the technology has become a specific target for health care investors.
Five Interesting Things To Know About Sulopenem (Orlynvah)
IDStewardship
JANUARY 13, 2025
BCIDP UNDER CONSTRUCTION Article PostedXXX Sulopenem etzadroxil and probenecid (Orlynvah) was recently approved in October 2024 for the treatment of uncomplicated urinary tract infections (uUTI) caused by Escherichia coli , Klebsiella pneumoniae , or Proteus mirabilis. 2024 Nov 2:S1198-743X(24)00507- X. Hosp Pharm. Dunne MW, et al.
Strategies for digital success in hospital pharmacy
Hospital Pharmacy Europe
JULY 1, 2025
In the face of increasing cyber threats – such as Synnovis in 2024, NHS Dumfries and Galloway in 2021 and WannaCry in 2017 – it’s imperative to have well-documented business continuity plans for all digital systems. It is impossible to prepare for all eventualities, but you can ensure you have these plans in place as a starting point.
What pharmacists should know about the new drugs approved in 2024
The Checkup by Singlecare
DECEMBER 26, 2024
2024 has been a busy year for new drugs. Notable new drugs approved in 2024 By staying up-to-date on the latest drug approvals, pharmacists can give new advice when working with patients and other healthcare providers. Zelsuvmi (berdazimer) Zelsuvmi received the green light from the FDA on January 5, 2024.
Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise
PharmaVoice
AUGUST 12, 2025
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Puerto Rico’s ongoing journey from manufacturing (..)
How Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab
PharmaVoice
JULY 24, 2025
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from How Bristol Myers Squibb uses AI to validate (..)
Research digest: Reviewing potentially inappropriate medications in elderly hospitalised patients
Hospital Pharmacy Europe
DECEMBER 30, 2024
BMC Geriatr 2024; Sept 30: DOI: 10.1186/s12877-024-05308-3. The researchers concluded that their findings underscore the need for multidisciplinary interventions to optimise pharmaceutical treatment in older adults in a hospital setting to reduce the consequences of PIMs in these patients. Reference Puig, T et al.
Statin statistics 2025
The Checkup by Singlecare
JUNE 5, 2025
Centers for Disease Control and Prevention (CDC) , 2024) High total cholesterol levels were most prevalent among adults between the ages of 40 and 59. ( Centers for Disease Control and Prevention (CDC) , 2024) High total cholesterol levels were most prevalent among adults between the ages of 40 and 59. ( about 11.3% about 11.3%
FDA’s CRLs reveal 74% of applications rejected for quality, manufacturing issues
Pharma Manufacturing
JULY 14, 2025
Out of 202 Complete Response Letters issued between 2020 and 2024, 150 involved quality/manufacturing issues, according to the regulator’s newly released documents.
V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults
Pharmacy Times
AUGUST 12, 2025
Published May 6, 2024. Published March 22, 2024. Published June 18, 2024. Last Updated October 2, 2024. Published October 21, 2024. Accessed August 11, 2025. Gallagher A. V116 Demonstrates Positive Immunogenicity for 21 Pneumococcal Serotypes. Pharmacy Times. Accessed August 11, 2025. Gallagher A. Pharmacy Times.
Restoring regulatory excellence “central” to UK life science competitiveness
European Pharmaceutical Review
DECEMBER 4, 2024
Article: Life sciences response to 2024 Autumn Budget The post Restoring regulatory excellence “central” to UK life science competitiveness appeared first on European Pharmaceutical Review.
AI Act: data governance and compliance strategy implications in Pharma
European Pharmaceutical Review
AUGUST 7, 2025
References AI Act, Regulation (EU) 2024/1689, Article 6(1)(a)-(b), and Supporting list: Annex I, AI Act (lists MDR, IVDR, and other relevant regulations) AI: CNIL Finalizes Its Recommendations On The Development Of AI Systems And Announces Its Future Work. Internet] CNIL.
Regulator and Funder? FDA’s Orphan Products Grants Program awards significant funding to help move promising treatments through clinical development
The FDA Law Blog
NOVEMBER 10, 2024
In October, FDA announced seven new clinical trial grants awarded in fiscal year (FY) 2024 – including one for a Phase 3 trial – totaling $17.2 Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field. million over the next four years.
Let's personalize your content